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Protein of Interest 
ESCRT III 
 Vps20 – Snf7 oligormerization initiation 
 Snf7 – monomeric units of the Snf7 oligomer 
 Vps2 – part of the Snf7 capping dimer 
 Vps24 – part of the Snf7 capping dimer 
 Vps4 – ATPase that disassembles the Snf7 complex 
 Bro1 – stabilizing element of the Snf7 oligomer 
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Abstract 
The endosomal sorting complexes required for transport (ESCRT) are protein 
complexes that remodel cellular membranes. The ESCRT III membrane machinery has 
been implicated in regulating membrane bound receptor proteins through the multi-
vesicular body (MVB) pathway, during the end of cytokinesis, and being manipulated by 
the HIV virus during infection. My thesis project focuses on the in vivo regulation of 
ESCRT III. Bro1 binding to the Snf7 protein polymer helped stabilize ESCRT III. With 
this understanding that Bro 1 stabilizes the Snf7 polymer, two questions can be posed: 
Does it block Vps4 mediated Snf7 disassembly? Or does it block Vps2 and Vps24 from 
capping the Snf7 polymer? The latter of these two questions is the focus of my thesis. 
My research has shown the interaction of the capping Vps2:Vps24 dimer to only slightly 
affect protein sorting in the ESCRT pathway.  
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Introduction 
 The compartmentalization of cells with membrane bilayers is crucial to the 
functionality and survival of any organism. This compartmentalization begins with the 
plasma membrane and is regulated by the processes of endocytosis and exocytosis. 
These two systems help regulate the plasma membrane composition so cells can 
respond to environmental signals. The ability of a cell to traffic proteins through the 
endocytic pathway is controlled and aided by many membrane remodeling protein 
systems. One of the most involved organelles with the endocytic pathway is the 
endosome. The ability to sort and direct proteins for degradation or recycling back to the 
plasma membrane is aided by the ESCRT machinery.  
Endocytic Pathway 
 The endocytic pathway plays a major role in helping to balance and maintain the 
composition of the plasma membrane. Plasma membrane equilibrium is controlled by 
the addition of secretory vesicles after fusion and subtraction of endocytic vesicles after 
invagination (Vita TA, 1995). Balance of these two events allows for the constant 
modification and alteration of the plasma membrane. The plasma membranes of 
organisms are in a constant 
state of remodeling, 
therefore the need for a 
specific and reliable system 
for membrane protein 
removal and recycling is 
needed (Zastrow, 2009). By 
allowing the plasma 
membrane to quickly 
remove or add membrane 
proteins, a cell can respond 
dynamically to 
environmental factors. The 
Figure 1: Cartoon representation of the endocytic pathway. The figure includes 
movement of vesicles from plasma membrane all the way until degradation at the 
lysosome or vacuole. (Daniel P Nickerson, 2007) 
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regulation via degradation or temporary suspension in a cytosolic vesicle of membrane 
proteins allows the cell to choose which option conserves more cellular energy 
(Zastrow, 2009).   
The regulation and control of different membrane proteins begins with the 
formation of clathrin-coated vesicles from the plasma membrane that travel to and are 
collected in the early endosome. (Nakano, 2007) Proteins that are targeted and placed 
into these clathrin coated vesicles are first ubiquitinated by one of the many ubiquitin 
conjugating enzymes that ubiquitinate the cytosolic side of membrane proteins. 
Ubiquitin (Ub) is a highly conserved 76 amino acid polypeptide that is linked to specific 
protein substrates targeted for degradation by a cascade of Ub-conjugation enzymes. 
Ubiquitination was first characterized to occur on soluble proteins that are 
polyubiquitinated via the attachment of a chain of four or more Ub subunits, which target 
these substrates for degradation by the proteasome (Weissman, 2001). Although 
membrane proteins are mainly regulated through endocytosis, cytosolic proteins can 
also find their way into endosomes via binding to a membrane-associated receptor. 
Upon fusion of the clathrin vesicle to an early 
endosome, the fate of membrane bound proteins is 
then regulated through the MVB (multivesicular body) 
biogenesis pathway. 
Multivesicular Body Biogenesis 
 The two main forms of protein degradation are 
through the proteasome or the MVB pathway. 
(Katzmann, 2007) The biogenesis of an endosome 
begins with an early endosome. Targeting of proteins 
to the endosome is controlled by the ubiquitination of 
membrane proteins. Direct evidence that Ub directed 
MVB sorting was provided in yeast by mutating the 
lysine residues of MVB cargo such as Cps1 and 
Phm5, which caused the buildup of these proteins in 
Figure 2: MVB biogenesis cartoon. The maturation of 
endosomes begins with any early endosome and through the 
sorting of ubiquitinated proteins into ILVs matures into a MVB, 
which then fuses with the vacuole or lysosome. (Katzmann, 
2007) 
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the vacuole membrane instead of the vacuole lumen. (Katzmann, 2007) After vesicles 
fuse with the early endosome, the ESCRT machinery is recruited to begin the process 
of forming intraluminal vesicles (ILVs). Membrane-bound proteins are actively sorted to 
different places in the cell through tightly choreographed processes, many of which 
center on the early endosome (James Hurley, 2011). The importance of sorting these 
proteins into different ILVs that can proceed to degradation or recycling lends to the 
importance of ESCRT machinery. As the endosome grows larger in size and contains 
more ILVs it matures into a multivesicular body. These MVBs then fuse with the vacuole 
in yeast or the lysosome in higher eukaryotic organisms. The ability of this maturation 
process to occur relies on the efficiency and effective sorting of proteins into the ILVs by 
the ESCRT complex. 
ESCRT Pathway 
Discovery and elucidation of the ESCRT pathway has been heavily intertwined with 
the deeper understanding of the multivesicular body. The quest to understand this 
imperative mechanism in endocytic protein regulation was initiated by the discovery of 
the first MVBs (Hurley, 2011). The discovery of 60 yeast vacuolar protein sorting (VPS) 
genes helped to provide direction to understanding endosome and protein sorting. The 
ESCRT machinery is made up of four complexes: ESCRT 0, I, II, and III. Recruitment of 
these different ESCRT complexes occurs in a chronological order, and each ESCRT 
complex requires the previous component to initiate formation of the complex. ESCRT 0 
is required for initiation of MVB biogenesis in yeast (Hurley, 2011). The next step in 
ESCRT recruitment is the formation of ESCRT I and ESCRT II, which create a large 
protein complex. This complex begins to drive the budding of the limiting membrane 
which would develop into the ILV.  
The main focus of this research project has been to further elucidate ESCRT III in 
vivo. ESCRT III polymerization is initiated by Vps20 binding that acts as the platform for 
Snf7 to begin creating the large oligomer complex that drives the scission of the ILV 
from the endosome membrane. During the polymerization of Snf7, an important 
stabilizer protein, Bro1, helps to support the large protein complex (Hurley, 2011).The 
capping of Snf7 by the dimer of Vps2 and Vps24 is the last step before the ILV pinches 
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away from the limiting membrane and into the lumen of the endosome (Figure 3). The 
dimer of Vps2 and Vps24 end the polymerization of Snf7 and prime the polymer for 
recycling by Vps4, an ATPase that hydrolyses ATP to break apart the Snf7 polymer 
(James Hurley, 2011). After the ILV has budded into the endosome lumen, the ESCRT 
machinery is recycled away from the surface of the endosome. This occurs so the 
ESCRT machinery can be recruited again by ubiquitinated proteins that have been 
shuttled from the plasma membrane to the endosome. 
 
ESCRT III Is Stabilized by Bro1 
 Within the dynamic network of ESCRT III, the interaction of Bro1mediated 
stabilizing of Snf7 has further been elucidated in how it controls the polymerization or 
recycling of the Snf7 polymer. Bro1 exerts its stabilization effect toward ESCRT-III 
downstream of complex assembly. The addition of exogenous Bro1 domain to ESCRT-
III was sufficient to protect the complex from Vps4-mediated disassembly (Wemmer M, 
2011). The binding of Bro1 to the Snf7 polymer helps provide mechanical stability, and 
also a barrier to recycling via Vsp4. With the increase of stability in Snf7 caused by Bro1 
binding, questions arise about the mechanism of how Bro1 inhibits or limits this 
recycling process. One option is that the capping dimer of Vps2 and Vps24 are both 
crucial to initiating disassembly of the Snf7 polymer, so Bro1 binding could be inhibiting 
these capping proteins or be regulating the recruitment of Vps4. 
 
Figure 3: Cartoon rendering of the ESCRT machinery bound to the endosome lumen. (Teis 2009 Cell) 
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ESCRT Pathway and Disease 
 Due to the dynamic nature of the ESCRT pathway and the effect it has on proper 
cell signaling it has been implicated in many human diseases. The most obvious impact 
of ESCRT function is through the regulation of receptors such as the EGFR (epidermal 
growth factor receptor), JAK (Janus Kinase)/ STAT (signal transducer and activator of 
transcription), and many other important plasma membrane associated receptor 
proteins (Saksena & Emr, 2009). In cancers such as acute myeloid leukemia, human 
prostate cancer, mammary carcinomas, squamous carcinomas, and glioblastomas, the 
ESCRT pathway has been inhibited to upregulate cell growth (Saksena & Emr, 2009). 
By inhibiting the ability of the ESCRT pathway to remove membrane receptors, cells 
can continue to grow and divide unchecked, resulting in life threatening diseases. 
Although increasing signal transduction from the plasma membrane is one avenue for 
cellular growth, modification in cytokinesis can also drive cancerous growth. The 
evidence showing the ESCRT III complex function during cytokinesis is due to its 
interaction with Tsg101 (tumor susceptibility gene) and the recruitment of ESCRT III to 
the midbody (Saksena & Emr, 2009). The implication of damaged cytokinesis function 
would lead to multinucleaie cells. The further elucidation and understanding of how this 
complex functions in vivo could provide potential drug targets and aid in improving 
patients quality of life. 
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Yeast Strains Used 
 Throughout this project, several yeast strains were used. All of the different knockout 
strains were created from the parental strain of SEY6210. All of the different gene 
deletions were made by homologus recombination. Each of the different yeast strains 
used can be modified and have multiple plasmids transformed to create the needed 
protein expressions for certain experiments. 
 
 
  
Yeast Strain Genetype
SEY6210 MATalpha leu2-3, 112 ura3-52 his3-∆200 trp1-∆901 lys2-∆801 suc2-∆9
GOY65 bro1∆::HIS3
GOY456 pep4∆ prb1∆ Vps2∆
GOY457 pep4∆ prb1∆ Vps2∆ Vps4∆
MBY3 Vps4∆
MWY24 snf7∆
MWY25 Snf7 L231A::Kan
DMY1 Bro1-GFP
DMY2 Bro1-GFP Vps4∆
GOY184 Vps2∆ Vps24∆
GOY282 Vps2-HA pep4∆
GOY283 Vps2-HA vps4∆ pep4∆
Figure 4: Table of yeast strain names and their associated genotypes. 
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Plasmid Name Insert Vector
pCR180 Sna3-GFP cloned from CRY117 which has a Longtine Sna3-GFP insert pRS415
pGO518 Sac1-Xho1 from pMB139 subcloned into pRS426 pRS426
pGO534 Spe1-Sal1 fragment from pGO530 subcloned into pRS416 pRS416
pGO780 Vps2 PCR product from ZW7 and ZW10 gapped into Sac1 site of pGO781 pRS426
pGO781 Vps23 PCR product from ZW13 and ZW14 gapped-repair into Kpn1 site of pRS 426 pRS426
pGO835 TK5p and TK6p amplification of MWM3 inseretd into Sac1 site of pRS423 pRS423
pMWM3 BRO1 5' UTS::bro1[1-387] pRS426
Primer Name Description Sequence
ZW7p (w)Vps2 5’UTR (500 bp upstream) inserted 5’end of Sac1 site in pRS426 gggatccactagttctagagcggccgccaccgcggtgGCAGCTGATGAATCAAACAG
ZW10p (C) Vps2 3’UTR (500bp downstream) (inserts 3’end of Sac1 in pRS426 and regenerates the Sac1 site) gcaattaaccctcactaaagggaacaaaagctggagctcGTTCCATTAGAAGTCGCTGA
ZW13p (W) Vps24 5’UTR (500 bp upstream)overhang anneals 5’end of Kpn1 site in agtgagcgcgcgtaatacgactcactatagggcgaattgCATTCTTAAAGCGTTCTGTG
ZW14p (C) Vps24 3’UTR (500 bp downstream) overhang anneals 3’end of Kpn1 site in pRS426 aattcgatatcaagcttatcgataccgtcgacctcgaggTGATATCGATTACCGTGGG
TK5p BOD 5’ UTR anneals 500bp upstream tail vps2 aacccttagggtccctttgctcagcgacttctaatggaacAAAAGGCAAACGGTTTGGAT
TK6p BOD 3’ UTR anneals 500 BP downstream tail in pgo780 gcgcgcaattaaccctcactaaagggaacaaaagctggagGATCTATGTTTTCCTCACTT
DN320p ML 1° fwd, KO VPS2 N/A
GP262p (C) VPS23 3'UTR N/A
Figure 6: Table of plasmids used for these experiments. Included are the names and genotypes and the original 
pRS series vector used to create them. 
Figure 5: Table of primers used when creating plasmids or gene knockout yeast strains. The figure includes a 
description of their use and the primer sequence. 
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Methods 
Yeast Culture 
The culturing methods used to grow yeast for experiments consisted of a two-
step process. Depending on the biochemical deficiency of the yeast strain, either 
minimal media (lacking specific amino-acids) or rich media was used to grow cells 
overnight. Then diluted an optical density of (OD600) .2 for yeast strains in rich media, 
and 0.3 O.D.s for cultures being grown in minimal media. Yeast cultures were then 
harvested between 0.5 – 0.8 O.Ds/ml and used for different experimental purposes.  
Yeast Transformation Protocol 
A standard yeast transformation protocol was performed when transforming a 
linear plasmid and PCR product, circular plasmid, or to create a knockout yeast strain 
with a PCR product. Cells were grown to mid-logarithmic stage of OD600= 0.5 – 0.8 and 
then harvested. These cells were then incubated at 30˚C in a solution of 0.1 M Lithium 
Acetate/TE. After the incubation period, DNA of interest is added with carrier DNA and 
incubated an hour at 30˚C. Immediately following the second incubation, the cells are 
heat shocked at 42˚C for 20 minutes. These transformed cells are spread on minimal 
media plates lacking the appropriate nutrients to select for the plasmid. For genetic 
deletions, transformations were plated on YPD agar plates containing 200μg/mL 
kanamycin. 
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Escherichia coli Transformation Protocol 
To transform bacteria with plasmids, the chemically competent XL1 Blue strain of 
e.coli cells are thawed on ice and added to pre-chilled closed circular DNA. Depending 
on the concentration of the DNA to be transformed, usually 100ng is added to the 
thawed bacteria. These cells are incubated on ice, and then heat shocked for 2 minutes. 
The bacterial cultures then recover in a liquid Luria broth (LB), at 37˚C. These 
transformed cells are then plated on LB agar plates containing 50μg/mL ampicillin. 
Plasmid Creation 
 The plasmids created for the purpose of studying ESCRT III were all pRS series 
vectors (Chee MK, 2012). This style of vector requires yeast auxotrophic for adenine, 
leucine, tryptophan, uracil, or histidine with the option of expressing these plasmids 
using a centromeric or 2μ high copy number (Chee MK, 2012). The pRS series of 
vectors also have an Escherichia coli driven promoter so plasmid can be purified from 
bacteria. The plasmids created consisted of a 2μ Vps2 and Vps24, a 2μ Vps24 alone, a 
centromeric Vps2 – HA tagged vector, and a 2μ BOD (Bro1 Domain) expression vector.  
 The gene of interest was amplified from yeast genomic DNA. The PCR product 
was then transformed into wildtype S.cerevisiae along with a pRS series vector that was 
linearized with a specific endonuclease. Using the endogenous machinery of the 
S.cerevisiae, the gene of interest homologously recombines into the pRS vector and is 
selected using the yeast marker within the pRS vector. These would then be purified 
from yeast using zymolase and transformed into bacteria. This then allows for the 
selection of one amplified plasmid per bacterial colony, which can be checked via PCR 
and gene knockout rescue experiments using the newly created plasmid.   
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Yeast Deletion Creation 
The yeast strains created for 
these experiments were made by 
homolgus recombination. This method 
of quickly knocking out genes in 
Saccharomyces cerevisiae takes 
advantage of using PCR to make an 
integration cassette (Longtine MS, 
1998). PCR primers are designed to 
homologously recombine with the gene 
of interest by replacing the gene with a 
selectable marker (Longtine MS, 1998). 
This system allows for specific and 
precise recombination and quick 
confirmation of knockouts. 
Yeast Lysate Preparation 
Yeast was inoculated from an overnight culture to a density of OD600 0.2/ml and 
grown to log phase OD600: 0.5 – 0.8/ml. Two different yeast lysis protocols were used 
one, a mechanical lysis and the other using osmotic pressure. For mechanical lysis, the 
cultures were frozen in liquid nitrogen, and then crushed under liquid nitrogen with a 
mortar and pestle, fracturing the cell walls of the yeast with mechanical grinding. The 
yeast cell powder was then lysed using a buffer containing TritonX – 100 and protease 
inhibitor cocktail, centrifuged to remove the insoluble portions of the cell, and the 
concentration of this lysate was measured using a BCA protein concentration assay.  
Osmotic lysis begins with removing the cell wall from log-phase yeast cultures with 
zymolase, resuspending the cells in low-osmotic buffer containing TritonX-100. 
Centrifuge these cultures to remove residual material. 
 
  
Figure 7: A diagram describing the Longtine knockout 
method. This method uses PCR products that homologusly 
recombined with the target gene to produce the new 
knockout mutant. 
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Immuno-Precipitation of Yeast Lysates 
The purpose of using immunoprecipitations is to pull down proteins of interest 
using antibodies specific to the protein you wish to study. For these 
immunoprecipitations, protein G sepharose beads were used. After washing the beads 
in lysis buffer, primary antibody specific to our protein of interest was added. 5μgs of 
anti-HA monoclonal antibody was added to the washed beads and rotated at 4˚C. 
Unbound αHA antibody is washed away and protein lysate is added. For each 
immunoprecipitation, 5 ODs or 500μgs were used. After letting this solution rotate at 
4˚C, the beads were gently centrifuged, then washed using buffers containing TritonX-
100 and NaCl to remove non-specific binding to the protein G beads. The beads were 
then dried and resuspened in Laemmli buffer, and all 5 ODs or 500μgs were loaded into 
a SDS-page gel.  
 
Western Blot Analysis of Protein Lysates 
  Western blots run in this thesis are 8 or 10% polyacrylamide gels. These gels 
help keep the boiled, and sample buffer prepared samples denatured and negatively 
charged while running with the electric current. Depending on the concentration of the 
samples, 10-15μl of sample were loaded each time and run in a SDS-page running 
buffer of a tris-glycine solution. These were then transferred to nitrocellulose paper 
overnight at 4˚C. The nitrocellulose blots were blocked with a 10% milk solution, then 
exposed to primary antibodies specific to the protein of interest. Both monoclonal and 
polyclonal antibodies were used, depending on the protein of interest. These blots were 
exposed for 1.5 hours at 21˚C or overnight at 4˚C. A secondary antibody with 
conjugated horseradish peroxidase (HRP) was applied to bind the primary antibody and 
allow for detection by chemilimunescence. 
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Results 
Snf7 Co-Immunoprecipitation with HA Tagged Vps-2 
 When attempting to understand how Bro1 helps stabilize the Snf7 polymer, the 
best technique to elucidate relative amounts of Snf7 polymer would be using an 
immunoprecipitation. By using an 
HA tagged Vps2 I pulled down 
Vps2 and then probed for a co-
immunoprecipitation of Snf7 when 
Bro1 is expressed normally or 
expressed at in increased level, in 
hopes of seeing the levels of Snf7 
protein change depending on the 
expression of Bro1 in the different 
yeast strains. 
For this experiment new, 
yeast knockout strains needed to 
be created. An already created 
yeast strain possessed knockouts 
of two important vacuole 
peptidases, pep4∆prb1∆, and 
another had both these peptidases 
knocked out along with Vps4∆, 
which is the ATPase that recycles the Snf7 complex. Using homologous recombination 
GOY456, pep4∆ prb1∆ vps2∆, and GOY457, pep4∆ prb1∆ Vps2∆ Vps4∆, were created. 
With these new knockout strains, Vps2-HA could be expressed on a plasmid so it could 
be pulled down using G-sephorase beads. A cartoon representation of this knockout 
process is described in figure 8. After the kanamycin gene was homologusly 
recombined, a 
PCR check was 
Figure 8: Longtine knockout system in yeast. This system was used 
to knockout Vps2 and then test to ensure a complete knockout was 
created. 
Figure 9: Agarose gel showing the knockout of Vps in several colonies. The kanamycin resistance 
gene is 1559 bps long while Vps2 is only 798bp so the difference could be observed. 
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performed using primers specific to the kanamycin resistance PCR product. ZW7 and 
ZW10 would amplify the gene locus, providing a longer fragment if the Vps2 gene had 
been homogusly removed with the Kan resistance gene. This is shown in figure 9, the 
larger bands in this image are the colonies possessing the kanamycin resistance gene 
while, the shorter fragments are the Vps2 gene.  After performing these reactions, the 
PCR gel showed that 3 of the colonies tested were positive for the kanamycin 
resistance gene. These could then be checked via western blot to ensure that the 
knockout was complete.  
With these knockouts made, I could begin to answer the question of how this 
capping protein causes a slight change in ESCRT III function. As discussed previously, 
Vps2 and Vps24 cap the Snf7 polymer, and this capping dimer recruits the ATPase 
Vps4 to begin recycling the complex (James Hurley, 2011). In an attempt to understand 
how Bro1, an effector protein that was shown to stabilize the Snf7 complex (Wemmer 
M, 2011), might be inhibiting the recruitment function of the capping dimer a co-
immunoprecipitation of Vps2-HA was devised. By immunoprecipitating Vps2 while 
overexpressing the Bro1 domain, I hoped to see altered levels of Snf7 polymer being 
pulled down. These constructs were transformed into, pep4∆ prb1∆ Vps2∆ and pep4∆ 
prb1∆ Vps2∆ Vps4∆, which are 
two yeast strains created 
specifically for this experiment. In 
figure 10 you can see the proof of 
concept for this experiment where 
Snf7 CO-IP is being performed 
when I pull down Vps2-HA. The 
presence of Snf7 in 
immunoprecipitation lanes with 
bands at 37Kd shows that a co-
immunoprecipitation occurred 
when Vps2-HA was pulled down. 
Figure 10 shows the difference in 
Figure 10: Western blot of Snf7 and HA showing the 
levels of expression of Snf7 when Bro1 is overexpressed. 
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expression of Snf7 when the Bro1 Domain is overexpressed. When overexpressed, 
there is more stabilization of the Snf7 polymer and Snf7 is able to be pulled down. 
When the BOD domain is overexpressed we could see similar levels of Snf7 in both of 
the yeast strains, but a larger amount may be present in the strain lacking Vps4 due to 
disassembly of Snf7 being inhibited. Moving forward efforts to pull down Vps2-HA in 
both overexpression and endogenous expression backgrounds to compare the levels of 
Snf7, but issues with these experiments have made the data un-conclusive. When 
comparing these two expression levels of Bro1, the endogenous and the 
overexpression, I will have a very clear picture of the effect of Bro1 on Snf7 stability.  
pGO780 and pGO781 Plasmid Creation 
The ESCRT pathway has been well studies for the past 10 years, but there are still 
many aspects of this fascinating pathway that have yet to be explored. As stated 
previously, the goal of this thesis was to understand the interactions of the Vps2 and 
Vps24 protein dimer and how it interacts with the Bro1 and the Snf7 polymer. It has 
been previously shown that Vps4 localizes to Snf7 both independently and via 
assistance from the capping dimer (Hurley, 2011). Previous work showed the increase 
of Snf7 polymer formation in the presence of the BOD, but there are still more questions 
to be answered. 
 In an attempt to further delve into this aspect of the ESCRT pathway 2μ high 
expression vectors needed to be created that contained Vps24 only, and Vps2 and 
Vps24 together. Creation of these constructs began with designing oligonucleotide 
primers to amplify these genes out of genomic yeast DNA. For the creation of pgo780 
both of these amplified elements were inserted into the empty pRS vector, pRS426 
which is a Uracil Section- 2μ plasmid. The Vps2 gene was inserted into the SacI site 
and the primer design allowed for reconstruction of the SacI site in the event it was 
needed for future experiments. As you can see from figure 1, the intron in Vps2 was 
included in the creation of this plasmid. 
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 Also inserted into this same vector was the Vps24 gene that was amplified with primers 
ZW13 and ZW14. After cutting the now inserted Vps2 plasmid with Kpn1, the amplified 
Vps24 gene was cloned into this cut site. Again, this cut site was regenerated in the 
event it would be needed for future experiments.  
 These two plasmids were checked for proper gene insertion by using the same 
primer sets to amplify the now inserted gene out of the plasmid. The primer pairs of 
ZW7p and ZW10p were used for Vps2. While the primer pair of ZW13p and ZW14p was 
used to amplify Vps24. The resulting amplification of these two genes out of plasmid is 
shown below in figure 2. This figure contains an 8% agarose and 3% ethidium bromide 
gel that has been loaded with two PCR reactions using the described primer sets from 
above. The first 2 bands after the 
base pair ladder are the Vps24 gene 
amplification primers, followed by the 
next two bands which are the Vps2 
amplification primers.  
 
 
 
Figure 11: pgo780and pgo781 amplification primer cassettes. Vps2 was created leaving the exon in the created 
plasmid. Vps24 does not have an intron in its gene. These genes were amplified out of isolated genomic yeast 
DNA. 
Figure 12: PCR products run on an agarose gel showing the 
amplification of Vps2 and Vps24 out of the newly created 
plasmids. 
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Recovery of Vps24∆ Mutants Using pGO781 
To test the effectiveness and functionality of pGO781, a yeast strain containing a 
Vps2∆Vps24∆ double mutation (GOY184) were transformed with this newly created 2μ 
Vps24 overexpression vector. GOY184 and a wild type strain SEY6210 were 
transformed with pGO781 (Vps24 overexpression) and pgo518 (Vps2 overexpression). 
The resulting yeast strains were subjected to western blot analysis using a αVps2 and 
αVps24 primary antibody.  As a 
positive control, a previously designed 
vector for Vps2 overexpression was 
used. From this experiment you can 
see the Vps2 vector rescues the 
expression of Vps2 in the GOY184 
strain and is also overexpressed in wild 
type. This can be concluded due to the 
dark bands present at 37kD, which is 
the molecular weight of both Vps2 and 
Vps24. Also, the bands present in the 
αVps24 portion of this gel show that the created Vps24 plasmid rescues Vps24 and 
produces a larger quantity in the wild type lysate. This experiment confirms the creation 
of this plasmid and its ability to overexpress Vps2. 
  
Figure 13: Western blot showing the recovery of Vps24 expression 
with pgo781 in Vps24 knockout yeast strains. 
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Rescue of GOY184 with pGO780 
When confirming the creation of 
pGO780 (the 2μ Vps2 and Vps24 
expression construct), the different 
isolated constructs were transformed 
into GOY184 (Vps2∆ Vps24∆). As a 
positive control both SEY6210 lysates 
and GOY184 transformed with a 
pGO518 (2μ Vps2) were included in 
this western blot analysis. In figure 4, 
you can see the 3 controls in the first 
3 lanes and then the 6 different 
constructs isolated from a bacterial 
purification of pGO780. The presence of a large overexpression band in the GOY184 
positive control (and this band absent in the negative control lane at 37 Kd) shows that 
our controls are working. The 3 other bands in lanes 7, 8 and 9 at 37kd are all yeast 
expressing pgo780. We can, therefore, conclude that the Vps2 expression portion of 
pGO780 is incorporated correctly. The 7th band colony in the western blot analysis was 
purified from the original bacterial colony and saved as a glycerol stock for later use. 
The difference in the bands between pgo518 expression and pgo780 expression could 
be due to the size of the vectors and the rate at which they are expressed and copied. 
 
  
Figure 14: Recovery of a knockout Vps2 yeast strain with 
pgo780. Created from pgo781, this recovery shows the 
proper insertion and creation of a Vps2 and Vps24 double 
expression vector. 
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Effect of Sna3 sorting with overexpression of Vps24 
With the newly created overexpression plasmids of Vps24, a question was posed 
on the impact on Snf7 polymerization when the Vps24 capping element was 
overexpressed. To test the effect of 
this capping, protein we used Sna3-
GFP. This membrane protein is 
trafficked through the ESCRT 
pathway of yeast to be degraded in 
the vacuole (Zastrow, 2009). In the 
event of an early capping of the 
ESCRT III complex, mis-sorting at 
the endosomal membrane would 
occur, and this protein would not be 
targeted to the vacuole for degradation. Therefore, we can study the impact of 
membrane protein sorting when using this GFP-tagged protein. Yeast strains MWY25 
and MWY24 were transformed with Sna3-GFP and the Vps2 and Vps24 overexpression 
plasmid. You can see in the MWY25 and GOY65 lanes a stronger expression of the 
GFP protein correlating to more mis-sorted Sna3-GFP protein. This shows that, in an 
event were capping proteins are overexpressed, we see a slight change in ESCRT 
sorting patterns due to the increase of GFP expression since Sna3-GFP is not being 
degraded and can be measured via western blot. 
In Vivo Imaging of Snf7 Complex with GST/GFP Immunoprecipitation 
 The Snf7 polymer is a very flexible and transient structure. Therefore the 
visualization of this complex with x-ray crystallography cannot be performed. Previous 
studies have shown the polymerization and disassembly of this complex using isolated 
protein and electron microscopy to view the Snf7 polymer in an in vitro setting 
(Shaogeng Tang, 2015). Ideally an in vivo image of nascent proteins would be the most 
ideal for understanding how the ESCRT III complex functions. The goal of this 
Figure 15: Western blot showing the effects of Sna3-GFP sorting when 
Vps24 is overexpressed. 
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experiment was to visualize the endogenous state of the ESCRT III complex using 
negative stain electron microscopy.  
 The yeast strains used for this experiment were DMY1, DMY2, and MBY3. The 
two DMY strains both have Bro1 with an integrated GFP tag, which we can use GFP 
specific nanobody for 
immunoprecipitation. The 
nanobody can still be isolated 
using glutathione sepharose 
beads and elution from the 
bead8s can be done using an 
excess glutathione solution to 
replace the protein bound 
nanobody. Figure 15 shows the 
proof of concept experiment that 
was performed. The top bands 
are the GFP protein expressed in 
the protein isolates. The presence 
of Snf7 on the glutathione bead 
fractions in this figure lead me to 
believe that a small amount of Bro1-GFP is needed to pull down the Snf7 complex. With 
this valuable information, I can begin to optimize this reaction so that we can pull down 
large quantities of the Snf7 complex. These will then be subjected to negative stain 
electron microscopy for visualizing the Snf7 polymer in its native state.  
 
 
 
 
 
Figure 16: Western blot showing the pull down of Bro1-GFP with 
nanobody specific to GFP. 
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Discussion & Future Directions 
  The ESCRT pathway is a crucial element to the health and longevity of any cell 
or organism. Manipulation and remodeling of the plasma membrane is important so 
cells can adapt and modify their extracellular receptors to respond to new stimuli and 
growth factors. By understanding how the ESCRT machinery assembles and 
dissembles, we can begin to apply this knowledge to elucidating novel therapies and 
solutions to diseases that are caused by mutations in this pathway. Although 
overexpression of the capping dimer does not specifically alter the ability of ESCRT III, 
you can see from the data that it modifies the levels of trafficked proteins slightly. These 
small buildups of protein concentrations in the endosome could eventually lead to 
further inhibition of the endocytic pathway. Future experiments to further understand this 
interaction would be using the double expression plasmid of Vps2 and Vps24 to see 
how overexpression of both of these capping proteins together affects protein sorting. 
Additionally, the use of a high-speed centrifugation and sucrose gradients to see how 
the levels of cytosolic Snf7 compare to the heavier Snf7 polymer could give us 
important information on how this cap functions. Binding Snf7 polymers prematurely can 
lock Snf7 in a polymer state and inhibit sorting or cap the polymer and target it for 
recycling to cytosolic monomers. This would provide an excellent insight into the 
interaction between the capping dimer and ESCRT III function. 
The interplay between the capping dimer of Vps2 and Vps24 and their possible 
antagonist Bro1 is vital to understanding the dynamic nature of ESCRT III. If you could 
control the polymerization and functionality of Snf7, ESCRT III targeted protein 
degradation could occur more efficiently. From the data, you can see that, when pulling 
down Vps2-HA, Snf7 is co-immunoprecipitated. This interaction shows how the capping 
and stabilizing the Snf7 polymer is important to the function of ESCRT III. Throughout 
the yearlong attempts to pull down Vps2-HA, several different approaches were used. 
The first approach used an integrated HA tag that was not expressing properly in the 
different yeast strains. The preliminary findings were drawn from a Vps2 knockout strain 
with a transformed Vps2-HA plasmid. Moving forward, attempts to understand this 
interaction would be to integrate a new Vps2-HA into the yeast genome and see how 
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the Snf7 polymer is co-immunoprecipitaed. Another avenue would be using a different 
tag, such as a Flag tag, to try and pull down the Vps2 protein and look for a co-
immunoprecipitation of Snf7. By further studying the interaction of Bro1 with Snf7 we 
can continue elucidate how the Snf7 polymer is maintained and manipulated to finalize 
the ILV formation process. 
Understanding of how the different elements of the ESCRT III complex interact 
lacks one crucial piece of evidence about how Snf7 complex orients itself in a 3 
dimensional space. The pulldown of Bro1-GFP has been shown to be possible, but the 
next step needs to be optimizing the experiment to produce the largest amount of the 
Snf7 polymer. The purpose of using negative stain EM would be to make the Snf7 
polymer stand out amongst the background when visualizing the polymer. The 
applications and implications of the ESCRT pathway are just beginning to be elucidated. 
Interactions between Vps2, Vps24, and Bro1 might create different Snf7 conformations. 
As we continue to understand how this dynamic system works and what we can do to 
manipulate it, these manipulations could lead to better treatments of human diseases 
associated with ESCRT mutations and also new technologies that can improve scientific 
research in ways we cannot foresee. 
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